Differences in disease prevalence as a source of the U.S.-European health care spending gap.

The United States spends more on health care than any European country. Previous studies have sought to explain these differences in terms of system capacity, access to technologies, gross domestic product, and prices. We examine differences in disease prevalence and treatment rates for ten of the most costly conditions between the United States and ten European countries using surveys of the noninstitutionalized population age fifty and older. Disease prevalence and rates of medication treatment are much higher in the United States than in these European countries. Efforts to reduce the U.S. prevalence of chronic illness should remain a key policy goal.

[1]  T. Vanitallie.  Prevalence of obesity. , 1996, Endocrinology and metabolism clinics of North America.

[2]  H. Hense,et al.  Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. , 2003, JAMA.

[3]  James H. Bigelow,et al.  Analysis of Healthcare Interventions that Change Patient Trajectories , 2005 .

[4]  K. Flegal,et al.  Secular trends in cardiovascular disease risk factors according to body mass index in US adults. , 2005, JAMA.

[5]  U. Reinhardt,et al.  It's the prices, stupid: why the United States is so different from other countries. , 2003, Health affairs.

[6]  J. Newhouse.  Commentary on Getzen's ''Aggregation and the Measurement of Health Care Costs'' , 2006 .

[7]  Zoe Oldfield,et al.  Disease and disadvantage in the United States and in England. , 2006, JAMA.

[8]  G. Colditz,et al.  The disease burden associated with overweight and obesity. , 1999, JAMA.

[9]  E. Berndt,et al.  The value of antihypertensive drugs: a perspective on medical innovation. , 2007, Health affairs.

[10]  A. Mokdad,et al.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.

[11]  Gerard F Anderson,et al.  U.S. health care spending in an international context. , 2004, Health affairs.

[12]  K. Thorpe,et al.  The rising prevalence of treated disease: effects on private health insurance spending. , 2005, Health affairs.

[13]  Quinn Mj.  Cancer Trends in the United States—A View From Europe , 2003 .

[14]  K. Thorpe.  The rise in health care spending and what to do about it. , 2005, Health affairs.